| Biomarker ID | 1538 |
| PMID | 25233230 |
| Year | 2014 |
| Biomarker | C-Terminal Fragment of PSA |
| Biomarker Basis | Concentration Based (ng/ml) |
| Biomolecule | Protein |
| Source | Urine |
| Subjects | Humans |
| Regulation | Upregulated in PCa (PCa: 117; Non PCa: 36.8) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Prostate Cancer Vs No Prostate Cancer |
| Type of Biomarker | Diagnostic |
| Cohort | 19 patients without Prostate Cancer and 50 with Prostate Cancer were included for the study |
| Senstivity | 86% |
| Specificity | 57.9% |
| AUC | 0.747 ± 0.0727 |
| Accuracy | NA |
| Level Of Significance | p=0.0016 |
| Method Used | MALDI-TOF |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |